Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease

Cognitive impairment is common in Parkinson's disease (PD), but often not improved by dopaminergic treatment. New treatment strategies targeting other neurotransmitter deficits are therefore of growing interest. Imaging the brain at rest (‘task-free') provides the opportunity to examine th...

Descripción completa

Detalles Bibliográficos
Autores principales: Borchert, Robin J, Rittman, Timothy, Passamonti, Luca, Ye, Zheng, Sami, Saber, Jones, Simon P, Nombela, Cristina, Vázquez Rodríguez, Patricia, Vatansever, Deniz, Rae, Charlotte L, Hughes, Laura E, Robbins, Trevor W, Rowe, James B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856878/
https://www.ncbi.nlm.nih.gov/pubmed/26837463
http://dx.doi.org/10.1038/npp.2016.18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856878/
https://www.ncbi.nlm.nih.gov/pubmed/26837463
http://dx.doi.org/10.1038/npp.2016.18

Ejemplares similares